Clinical Trial: A Study to Test How Well Different Doses of BI 3821001 Are Tolerated by Healthy People

U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07908004) titled 'A Study to Test How Well Different Doses of BI 3821001 Are Tolerated by Healthy People' on Oct. 26.

Brief Summary: The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3821001 administrations of multiple rising doses.

Study Start Date: Nov. 03

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: BI 3821001

BI 3821001

DRUG: Placebo

Placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Boehringer Ingelheim

Disclaimer: Curated by HT Syndication....